The data: AI models that saw a pharma ad recommend the advertised treatment in 48% of responses to a clinical case, compared with 35% without the ad, per a new study from Icahn School of Medicine at Mount Sinai. Researchers tested 12 AI models from companies including Google, OpenAI, and Anthropic. Ads shifted recommendations toward the advertised drug when it was a reasonable treatment option but did not increase recommendations for inappropriate or unsupported treatments.
Why it matters: As physicians use AI for medical information and treatment guidance, pharma advertising could influence which drugs AI tools recommend when multiple treatments are clinically appropriate.
AI is already a regular part of many physicians’ workflows and is shaping clinical decisions. Some 52% use AI at work once or more a day, and another 22% use it at least once a week, according to Wolters Kluwer’s June Future Ready Healthcare survey.
In a separate March Remedy Edge survey of 1,156 global healthcare providers, 12% said AI significantly influences their clinical decision-making, while another 61% reported it has at least some influence.
Physician-focused AI platforms give pharma companies a way to reach doctors as they research treatment options. Nearly 1 million US clinicians submitted 271 million queries to the ad-supported medical AI platform OpenEvidence between January 2024 and June 2026, with 33% of queries focused on treatment and management decisions, according to a study published in October on JAMA Network. Jeff Tangney, CEO of Doximity, said on the company's Q3 earnings call that 16 of the top 20 pharma companies have purchased its AI Search advertising product.
Implications for pharma marketers: Pharma AI advertising to physicians could extend beyond sponsored placements alongside AI-generated answers. The Mount Sinai findings suggest ads help brands win AI recommendations in treatment categories with multiple appropriate drug options. Physician-focused platforms such as OpenEvidence and Doximity keep sponsored ads separate from the text of their AI-generated clinical responses. Marketers should measure how different AI ad formats affect drug visibility and whether they influence which treatments AI recommends to physicians.
You've read 0 of 2 free articles this month.
685 Third Avenue21st FloorNew York, NY 100171-800-405-0844
1-800-405-0844[email protected]